Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Heterocyclic carbon compounds containing a hetero ring...
Patent
1997-12-19
1998-12-01
Bernhardt, Emily
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Heterocyclic carbon compounds containing a hetero ring...
514255, 544360, 544392, A61K 31495, C07D40104, C07D295135
Patent
active
058439480
ABSTRACT:
Compounds having fibrinogen receptor-antagonistic activity, of the general formula I ##STR1## in which Z is oxygen or a methylene group,
REFERENCES:
patent: 5273982 (1993-12-01), Alig et al.
patent: 5442064 (1995-08-01), Pieper et al.
patent: 5563268 (1996-10-01), Linz et al.
Eldred et al., "Orally Active Non-Peptide Fibrinogen Receptor GpIIb/IIIa) Antangonists . . . " J. Med. Chem., vol. 37:3882-85 1994).
Judkins et al., "A Versatile Synthesis of Amidines From Nitriles Via Amidoximes", Synthetic Commun., vol. 26(23):4351-67 (1996).
Antel Jochen
Bielenberg Gerhard-Wilhelm
den Hartog Jack A. J.
Kehrbach Wolfgang
Kruse Chris G.
Bernhardt Emily
Solvay Pharmaceuticals GmbH
LandOfFree
Piperazinophenyl- and piperazinophenyloxycarboxylic acid derivat does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Piperazinophenyl- and piperazinophenyloxycarboxylic acid derivat, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Piperazinophenyl- and piperazinophenyloxycarboxylic acid derivat will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-2395848